The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tereshchenko S.N.

National medical research center of cardiology MH RF

Zhirov I.V.

National medical research center of cardiology MH RF

Kochetov A.G.

Tsentr kardiokhirurgii i tsentr urologii 3-go Tsentral'nogo voennogo klinicheskogo gospitalia im. A.A. Vishnevskogo MO RF, Moskovskaia oblast', Krasnogorsk

Translational medicine in Russian cardiology: a new stage or repetition of the past?

Authors:

Tereshchenko S.N., Zhirov I.V., Kochetov A.G.

More about the authors

Journal: Therapeutic Archive. 2016;88(9): 5‑9

DOI: 10.17116/terarkh20168895-9

Read: 4725 times

Download PDF (RU)
Contact the author
Table of contents

TRANSLATIONAL MEDICINE IN RUSSIAN CARDIOLOGY: A NEW STAGE OR REPETITION OF THE PAST?
TRANSLATIONAL MEDICINE IN RUSSIAN CARDIOLOGY: A NEW STAGE OR REPETITION OF THE PAST?

To cite this article:

Tereshchenko SN, Zhirov IV, Kochetov AG. Translational medicine in Russian cardiology: a new stage or repetition of the past? Therapeutic Archive. 2016;88(9):5‑9. (In Russ.)
https://doi.org/10.17116/terarkh20168895-9

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The influence of demo­graphic factors and major como­rbidities on serum circulating regu­latory microRNAs in patients with coro­nary artery athe­rosclerosis and thoracic aortic aneurysm: a single-center cohort study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):174-182
Serum expression of microRNA-21, microRNA-125a, microRNA-125b, microRNA-214 in coro­nary artery disease patients. Russian Cardiology Bulletin. 2025;(2):13-19
The Webiomed.DHRA deci­sion-making support system for medi­cal examinations in the Russian Fede­ration: a cost-effectiveness analysis. Medi­cal Technologies. Asse­ssment and Choice. 2025;(3):61-73
Extracellular vesi­cles and their role in endo­metrial rece­ptivity in patients with recu­rrent implantation failure. Russian Journal of Human Reproduction. 2025;(4):46-52
Modern stra­tegies for early diagnosis of cardiotoxicity caused by chemotherapy. Russian Journal of Preventive Medi­cine. 2025;(11):113-120
Possibilities of inte­ractions of circular RNAS with nucleic acids and proteins. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(4-2):28-32
Diagnostic pote­ntial of small non-coding RNAs in pipe­lle biopsy mate­rial of euto­pic endo­metrium. Russian Journal of Human Reproduction. 2026;(1):92-102
Abstract:

The brief review gives the experience in using the concept of translational medicine in the practical activities of the Russian Cardiology Research and Production Complex in the past 25 years of its existence. It outlines the possible ways of developing this area in Russian medicine to solve crucial scientific and practical tasks.

Keywords:

translational medicine
cardiology
microRNA

Authors:

Tereshchenko S.N.

National medical research center of cardiology MH RF

Zhirov I.V.

National medical research center of cardiology MH RF

Kochetov A.G.

Tsentr kardiokhirurgii i tsentr urologii 3-go Tsentral'nogo voennogo klinicheskogo gospitalia im. A.A. Vishnevskogo MO RF, Moskovskaia oblast', Krasnogorsk

Close metadata

References:

  1. 70 years - FGBU Russian Cardiology Science and Production Complex of Ministry of health of Russian Federation. Moscow; Complect Service; 2015. (In Russ.)
  2. Burke JD, Pincus HA, Pardes H. The clinician-researcher in psychiatry. Am J Psychiatry. 1986;143(8):968-975.  doi:10.1176/ajp.143.8.968
  3. Ipatova O, Medvedeva N, Archakov A, Grigor'ev A. Translational medicine as a way from fundamental biomedical science to public health services. Vestnik RAMN. 2012;6:57-65. (In Russ.)
  4. Paltsev M, Belushkina N. Translational medicine - a new stage of molecular medicine development. Molekularnaya meditsina. 2012;4:3-9. (In Russ.)
  5. Feldman A. Does Academic Culture Support Translational Research? Clin Translat Scie. 2008;1(2):87-88  doi:10.1111/j.1752-8062.2008.00046.x
  6. Sarkar I. Biomedical informatics and translational medicine. J Translational Med. 2010;8(1):22.  doi:10.1186/1479-5876-8-22
  7. Feldman A, Koch W, Force T. Developing Strategies to Link Basic Cardiovascular Sciences with Clinical Drug Development: Another Opportunity for Translational Sciences. Clin Pharmacol Ther. 2007;81(6):887-892.  doi:10.1038/sj.clpt.6100160
  8. Birmingham K. What is translational research? Nature Med. 2002;8(7):647-650.  doi:10.1038/nm0702-647
  9. Lewis B, Burge C, Bartel D. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets. Cell. 2005;120(1):15-20.  doi:10.1016/j.cell.2004.12.035
  10. Iaconetti C, Gareri C, Polimeni A, Indolfi C. Non-Coding RNAs: The «Dark Matter» of Cardiovascular Pathophysiology. IJMS. 2013;14(10):19987-20018. doi:10.3390/ijms141019987
  11. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang C. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997-1006. doi:10.1038/cr.2008.282
  12. Weber J, Baxter D, Zhang S, Huang D, How Huang K, Jen Lee M, Galas D, Wang K. The MicroRNA Spectrum in 12 Body Fluids. Clin Chem. 2010;56(11):1733-1741. doi:10.1373/clinchem.2010.147405
  13. Kochetov A, Zhirov I, Masenko V, Gimadiev R, Lyang O, Tereshchenko S. Perspectives of using microRNA in the dyagnosis and therapy of heart failure. Kardiologicheskii vestnik. 2014;2:62-67. (In Russ.)
  14. Kochetov A, Lyang O, Gimadiev R, Zhirov I, Skvortsov A, Zaseeva A, Bosykh E, Masenko V, Tereshchenko S. Expression of circulating microRNA in chronic heart failure in patients with cardiovascular pathologies. Laboratornaya sluzhba. 2016;1:26-32. (In Russ.) doi:10.17116/labs20165126-32
  15. Roy S, Khanna S, Hussain S, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo G, Sen C. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res. 2009;82(1):21-29.  doi:10.1093/cvr/cvp015
  16. Tijsen A, Creemers E, Moerland P, de Windt L, van der Wal A, Kok W, Pinto Y. MiR423-5p As a Circulating Biomarker for Heart Failure. Circulation Res. 2010;106(6):1035-1039. doi:10.1161/circresaha.110.218297
  17. Matkovich S, Van Booven D, Youker K, Torre-Amione G, Diwan A, Eschenbacher W, Dorn L, Watson M, Margulies K, Dorn G. Reciprocal Regulation of Myocardial microRNAs and Messenger RNA in Human Cardiomyopathy and Reversal of the microRNA Signature by Biomechanical Support. Circulation. 2009;119(9):1263-1271. doi:10.1161/circulationaha.108.813576
  18. Bernardo B, Gao X, Winbanks C, Boey E, Tham Y, Kiriazis H, Gregorevic P, Obad S, Kauppinen S, Du X, Lin R McMullen J. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proceedings of the National Academy of Sciences. 2012;109(43):17615-17620. doi:10.1073/pnas.1206432109
  19. Huang Y, Qi Y, Du J, Zhang D. MicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4. Expert Opinion on Therapeutic Targets. 2014;1-11.  doi:10.1517/14728222.2014.961424
  20. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N. Plasma miR-208 as a Biomarker of Myocardial Injury. Clin Chem. 2009;55(11):1944-1949. doi:10.1373/clinchem.2009.125310
  21. Gidlöf O, Andersson P, van der Pals J, Götberg M, Erlinge D. Cardiospecific microRNA Plasma Levels Correlate with Troponin and Cardiac Function in Patients with ST Elevation Myocardial Infarction, Are Selectively Dependent on Renal Elimination, and Can Be Detected in Urine Samples. Cardiology. 2011;118(4):217-226.  doi:10.1159/000328869
  22. Gidlöf O, Smith J, Miyazu K, Gilje P, Spencer A, Blomquist S, Erlinge D. Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. BMC Cardiovasc Disord. 2013;13(1):12.  doi:10.1186/1471-2261-13-12
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.